Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt joined Thomas Warner from Proactive on World Multiple Sclerosis day to talk about progress on the company's novel MS treatment.
Dr Vitt explains what differentiates Immunic's molecule from other potential forms of treatment, saying that ultimately the company hopes to "offer patients a new kind of treatment."